Journal articleEur J Cancer2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.
- Journal
- Eur J Cancer
- Published
- 12 September 2019
- Citations
- 25
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 1
- Its registry lists this paper as resultsPhase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types NCT00633789↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.